Developers of mRNA therapeutics face an increasingly complex landscape: rising expectations for potency and durability, ...
Proteins need to interact in a complex manner for a so-called 'messenger RNA' (mRNA) to be created in human cells from a precursor molecule. mRNA provides a blueprint for proteins; the first vaccines ...
Scientists have discovered the internal shape of tiny drug-delivery particles – called lipid nanoparticles – has a big impact on how well our cells absorb them, paving the way to more efficient ...
Angie Hilliker has received funding from the National Institutes of Health. While using mRNA as medicine is new, mRNA has been inside you for your entire life. The cells in your body create mRNAs that ...
In the wake of its breakout COVID-19 success with Pfizer, BioNTech’s globetrotting mRNA ambitions are taking shape. The company’s latest move? A strategic partnership in the Land Down Under. Friday, ...
Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results